L. Widmer

发表

Fate of contaminating t(14; 18)+ lymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cells.

R. Stahel, G. Pichert, L. Jost, 1996, Blood.

Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research.

K. Rufibach, R. Stupp, J. Bernhard, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose chemotherapy and autologous bone marrow transplantation for malignant lymphomas.

R. Stahel, G. Pichert, L. Jost, 1995, Cancer treatment reviews.

Selection and immunomagnetic purging of peripheral blood CD34+ cells for autologous transplantation in B-cell non-Hodgkin's lymphomas.

M. Kurrer, R. Stahel, G. Pichert, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Original Index of pretreatment intensity predicts outcome of high-dose chemotherapy and autologous progenitor cell transplantation in chemosensitive relapse of Hodgkin's disease

R. Stahel, L. Jost, L. Widmer, 2005 .

Index of pretreatment intensity predicts outcome of high-dose chemotherapy and autologous progenitor cell transplantation in chemosensitive relapse of Hodgkin's disease.

R. Stahel, L. Jost, L. Widmer, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Ectopic expression of human topoisomerase IIα fragments and etoposide resistance in mammalian cells

R. Stahel, S. Gasser, A. Soltermann, 2000, International journal of cancer.

Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03.

R. Stupp, L. Bubendorf, R. Stahel, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07.

R. Winterhalder, G. Bodoky, F. Bosman, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial.

R. Herrmann, R. Winterhalder, L. Jost, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant chemoradiation (CRT) with or without panitumumab (Pan) in patients with K-ras unmutated, locally advanced rectal cancer (LARC): Final results of a randomized multicenter phase II trial (SAKK 41/07).

R. Winterhalder, G. Bodoky, F. Bosman, 2015 .

Principled Drug-Drug Interaction Terms for Bayesian Logistic Regression Models of Drug Safety in Oncology Phase I Combination Trials

D. Ohlssen, S. Weber, L. Widmer, 2023, 2302.11437.